Instructions

ZOOM IN by clicking on the page. A slider will appear, allowing you to adjust your zoom level. Return to the original size by clicking on the page again.

MOVE the page around when zoomed in by dragging it.

ADJUST the zoom using the slider on the top right.

ZOOM OUT by clicking on the zoomed-in page.

SEARCH by entering text in the search field and click on "In This Issue" or "All Issues" to search the current issue or the archive of back issues
respectively.

PRINT by clicking on thumbnails to select pages, and then press the
print button.

SHARE this publication and page.

ROTATE PAGE allows you to turn pages 90 degrees clockwise or counterclockwise.Click on the page to return to the original orientation. To zoom in on a rotated page, return the page to its original orientation, zoom in, and
then rotate it again.

CONTENTS displays a table of sections with thumbnails and descriptions.

ALL PAGES displays thumbnails of every page in the issue. Click on
a page to jump.

MEDICAL
PARTNERSHIP
by Jeffrey M. Soares
S
i nce its establishment more than 30 years
ago, the U.S. Army Medical Materiel
Development Activity (USAMMDA) has
been partnering with industry to create
effective medical product solutions to support our
warfighters in the field and at home. Over the
years, USAMMDA’s multiple project management
offices have overseen the development of numer-
ous medical products and devices, which include
the antimalarial drug tafenoquine, an adenovirus
vaccine, freeze-dried plasma, the Chemical Patient
Protective Wrap, the Environmental Sentinel
Biomonitor and the Laborator y Assay for Trau-
matic Brain Injury. In so doing, the organization
has used a number of approaches to secure the
right type of partnership for a given product, such
as various types of contracting methods, coop-
erative research and development agreements
(CR ADAs) and “open campus” models.
As a subordinate command of the U.S. Army
Medical Research and Materiel Command at
Fort Detrick, Maryland, the USAMMDA team
is a partnership of military, federal civilian and
contract professionals working together in support
of the organization’s mission to develop and deliver
quality medical capabilities to protect, treat and
sustain the health of our nation’s service members.
However, given the nature of medical product
development in the world of Army acquisition,
USAMMDA does not have the manufacturing
capability to carry a product all the way through
the life cycle pipeline on its own. Therefore, the
command uses its expertise in project manage-
ment and reaches out to commercial partners to
create the best product to satisfy a given military
requirement.
In addition to creating products for troops on the
battlefield, USAMMDA works to find solutions to
treat wounded warfighters returning from battle.
While the scars of traumatic brain injury and post-
traumatic stress disorder may not be readily visible,
the damage of catastrophic wounds can clearly be
seen, and the command has multiple teams that
look to discover treatment options for these types
of physical and emotional injuries.
USAMMDA works with military, federal civilian
and contract professionals to develop and deliver
quality medical products.
HTTPS://ASC.ARMY.MIL
61
SCIENCE&TECHNOLOGY